Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is -37.95% vs 3.71% in Sep 2025
Standalone Net Profit
YoY Growth in quarter ended Sep 2026 is -420.15% vs 18.67% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is -233.25% vs 32.96% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 4,290.91% vs -21.43% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025
Compare Quarterly Results Of Evonile Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is -46.01% vs 14.64% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -37.95% vs 3.71% in Sep 2025
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is -340.73% vs 27.56% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -420.15% vs 18.67% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is -191.15% vs 69.30% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -233.25% vs 32.96% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 7,950.00% vs -14.29% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 4,290.91% vs -21.43% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025